insurance changes to glp-1 drugs MCT2D Navigating Insurance for GLP-1 Medication:
Description
95%CI 0.421.17), for those who were treated with such agents at enrolment, the HR was as low as 0.23 and statistically significant in the post-hoc testing (95%CI 0.050.97) (Lam et al., 2021)
2 Low risk of hypoglycemia GLP-1 agonists also have a low risk of hypoglycemia
Viral gastroenteritis may be known more commonly as the stomach flu and has similar symptoms to medication-caused gastroenteritis
2012;2:e51e51
Further, whilst some anecdotal and qualitative data suggests that GLP-1 RAs effectively reduced food-related thoughts (food noise) and support healthier eating behaviours, more objective data is needed
